Name: Sagimet Biosciences Inc. (SGMT) Financial Statements
Creator: FinSpry

Sagimet Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Sagimet Biosciences Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	2.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	2.00	0.00	0.00	0.00
Operating Expenses
Research & Development	38.44	19.78	24.92	19.34	8.18
Selling, General & Administrative	16.01	12.96	6.14	4.38	3.22
Operating Expenses	54.45	32.74	31.06	23.72	11.40
Operating Income	-54.45	-30.74	-31.06	-23.72	-11.40
Other Income/Expense
Interest Income	8.89	2.86	0.55	0.03	0.03
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	8.89	0.00	0.00	-0.75	0.00
Income
Income Before Tax	-45.57	-27.88	-30.50	-24.44	-11.37
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-45.57	-27.88	-30.50	-24.44	-11.37
Net Income - Continuous Operations	-45.57	-27.88	-30.50	-24.44	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-54.45	-30.74	-31.06	-23.72	-11.40
EBIT	-54.45	-30.74	-31.06	-23.72	-11.40
Depreciation & Amortization	0.00	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-1.00	-3.00	-1.00	-199.00	-118.00
Diluted EPS	-1.00	-3.00	-1.00	-199.00	-118.00
Basic Shares Outstanding	31.35	10.46	22.17	0.12	0.10
Diluted Shares Outstanding	31.35	10.46	22.17	0.12	0.10